| Education Background |
2000-2004 Bachlor, Pharmaceutical Sciences, School of Pharmacitical Science, Jilin University
2004-2006 Master, Medicinal Chemistry, School of Pharmacitical Science, Jilin University
2006-2009 Ph.D. ,Microbiology and Biochemical Pharmacy， College of Life Sciences, Jilin University
|
| Scientific Research Achievements |
Publications:
1. Yilin Liu, Yuming Song, Yingju Xu, Meixu Jiang, Haibin Lu. (2022). Design, synthesis, and biological evaluation of a novel series of 2-(2,6-dioxopiperidin-3-yl)isoquinoline-1,3(2 H,4 H)-dione derivatives as cereblon modulators, Journal of enzyme inhibition and medicinal chemistry, 37(1), 1715-1723.
2.Li Yanjie, Li Yongqiang, Yang Liu, Liu Zhi, Zhang Ruimeng, Zhen Xiaowen, Lu Haibin, Wang Ensi. (2021). Design, synthesis and biological evaluation as immunosuppressant of amino alcohol derivatives containing thioether. Materials Express, 11(5), 773-780.
3.Mu Xupeng, Bai Liting, Xu Yingju, Wang Jingyao, Lu Haibin. (2019). Protein targeting chimeric molecules specific for dual bromodomain 4 (BRD4) and Polo-like kinase 1 (PLK1) proteins in acute myeloid leukemia cells. Biochemical and Biophysical Research Communications, 521, 833-839.
4. Wang Shihui, Li Haiyan, Wang Yue, Gao Yang, Yu Shanshan, Zhao Qianqian, Jin Xiangqun，Lu Haibin. (2018). Design and Synthesis of Proteolysis Targeting Chimeras for Inducing BRD4 Protein Degradation. Chemical Research in Chinese Universities. 34(2), 221-228.
5. Wang Shihui, Song Yuming, Wang Yue, Gao Yang, Yu Shanshan, Zhao Qianqian, Jin Xiangqun, Lu Haibin. (2018). Design and synthesis of novel bispecific molecules for inducing BRD4 protein degradation. Chemical Research in Chinese Universities, 34(1), 67-74.
|
